Facebook Twitter LinkedIn Instagram Email Printer Google Plus

Providers

Health systems have seen a breakthrough in agility. Analyzing earlier experiences will drive its sustainability.

Principal, Health & Life Sciences, Oliver Wyman
Principal, Health & Life Sciences, Oliver Wyman
Partner and Chief Medical Officer, Health and Life Sciences, Oliver Wyman
Partner, Health and Life Sciences, Oliver Wyman
Partner, Organizational Effectiveness, Health and Life Sciences, Oliver Wyman
Partner, Health & Life Sciences, Oliver Wyman

Experts predict healthcare's "new normal" will come in late 2021. This webinar explores questions leaders must ask today to stay resilient tomorrow.

Co-Founder and CEO, Alpha Health
Partner, Health & Life Sciences, Oliver Wyman

Q&A with Landmark Health on Their Pandemic Strategy

Lessons for healthcare leaders on caring for an especially vulnerable senior population.

Chief Medical Officer, Landmark Health
Director, Strategy & Corporate Development, Landmark Health
Principal, Health and Life Sciences, Organizational Effectiveness, Oliver Wyman

The pandemic may transform the foundation that innovative collaborations are based on.

Partner, Health & Life Sciences, Oliver Wyman
Associate, Health & Life Sciences, Oliver Wyman
Principal, Oliver Wyman
Senior Consultant, Oliver Wyman

Executives discuss the COVID-19 financial fallout and what future subsequent peaks might look like for health systems.

Insights in your inbox

Subscribe

Market dynamics are ripe for M&A activity. But before being enticed by a mirage, leaders must revisit old lessons.

Principal, Health and Life Sciences, Oliver Wyman
Partner, Health & Life Sciences, Oliver Wyman
Partner, Health & Life Sciences, Oliver Wyman
Partner, Health and Life Sciences, Oliver Wyman

Chinese platforms and service providers are experiencing a spike in tech adoption and utilization amidst the pandemic.

Partner, Health & Life Sciences, Oliver Wyman
Principal, Health & Life Sciences, Oliver Wyman

The coronavirus is transforming the status quo of cost, sustainability, and affordability.

Partner, Health and Life Sciences, Oliver Wyman
Global Head, Provider, Health and Life Sciences, Oliver Wyman
Partner, Health & Life Sciences, Oliver Wyman

The aviation and finance industries' past experiences accessing federal programs mirror providers' current experiences.

Partner, Health & Life Sciences, Oliver Wyman
Partner, Health and Life Sciences, Oliver Wyman

Four tactical considerations to ensure your pandemic reaction is expedited, purposeful, and meaningful.

Principal, Health and Life Sciences, Organizational Effectiveness, Oliver Wyman
Senior Advisor, Health & Life Sciences, Oliver Wyman
Principal, Health & Life Sciences, Oliver Wyman
Partner, Health & Life Sciences, Oliver Wyman

Insights in your inbox

Subscribe